First Nebraska Trust’s Organon & Co OGN Stock Holding History

First Nebraska Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,330	Closed	-$291K	–	178
2022 Q1	$291K	Sell	8,330 -62	-0.7%	-$2.12K	0.03%	143
2021 Q4	$256K	Sell	8,392 -136	-2%	-$4.43K	0.03%	158
2021 Q3	$280K	Sell	8,528 -49	-0.6%	-$1.57K	0.04%	144
2021 Q2	$260K	Buy	+8,577	New	+$282K	0.03%	151

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Nebraska Trust's OGN Position: Q2 2022 in Review

First Nebraska Trust sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 8,330 shares — an estimated $291K sold.

First Nebraska Trust first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $291K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

First Nebraska Trust reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
First Nebraska Trust sold 8,330 Organon & Co shares in Q2 2022, an estimated $291K.
First Nebraska Trust first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
First Nebraska Trust's Organon & Co position peaked at $291K in Q1 2022.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on First Nebraska Trust's 13F filing for Q2 2022, filed 23 Jun 2026.